Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Phreesia filings document the company’s operating results, material agreements, capital structure and governance as a public healthcare technology company. Recent Form 8-K disclosures include quarterly financial results, stakeholder letters and earnings-call materials, along with material definitive agreements connected to credit facilities, acquisition financing and receivables arrangements.
The filing record also documents the completed AccessOne acquisition, the use and refinancing of related debt, and subsidiary arrangements involving AccessOne Funding and AccessOne MedCard. Governance disclosures include board composition changes, director compensation matters and shareholder-voting subjects, while capital-structure disclosures cover secured revolving credit, bridge-loan obligations and receivables purchase agreements.
Evan Roberts, President, Provider Solutions at Phreesia, Inc. (PHR), reported a sale of 3,761 shares of common stock on 09/16/2025 at a weighted-average price of $23.2844 per share. After the transaction, the reporting person beneficially owned 726,837 shares. The filing states the shares were disposed of in non-discretionary transactions under the issuer's mandatory sell-to-cover policy to satisfy tax withholding obligations related to the settlement of restricted stock units. The sale was signed via power of attorney on 09/18/2025.
Evan Roberts, President, Provider Solutions at Phreesia, Inc. (PHR), reported a sale of 3,761 shares of common stock on 09/16/2025 at a weighted-average price of $23.2844 per share. After the transaction, the reporting person beneficially owned 726,837 shares. The filing states the shares were disposed of in non-discretionary transactions under the issuer's mandatory sell-to-cover policy to satisfy tax withholding obligations related to the settlement of restricted stock units. The sale was signed via power of attorney on 09/18/2025.
Phreesia insider sale by SVP, Human Resources. Amy Beth VanDuyn sold 1,762 shares of Phreesia, Inc. (PHR) on 09/16/2025 at a weighted average price of $23.2844 per share. The filing shows 112,479 shares beneficially owned by the reporting person after the transaction, held directly. The sale was disclosed as a non-discretionary, mandatory sell-to-cover to satisfy tax withholding obligations related to the settlement of restricted stock units; proceeds were realized across multiple transactions at prices ranging from $22.83 to $23.69 per share. The Form 4 was signed by Power of Attorney on 09/18/2025.
Phreesia insider sale by SVP, Human Resources. Amy Beth VanDuyn sold 1,762 shares of Phreesia, Inc. (PHR) on 09/16/2025 at a weighted average price of $23.2844 per share. The filing shows 112,479 shares beneficially owned by the reporting person after the transaction, held directly. The sale was disclosed as a non-discretionary, mandatory sell-to-cover to satisfy tax withholding obligations related to the settlement of restricted stock units; proceeds were realized across multiple transactions at prices ranging from $22.83 to $23.69 per share. The Form 4 was signed by Power of Attorney on 09/18/2025.
Phreesia, Inc. (PHR) filed a Form 144 reporting a proposed sale of 93 common shares through Fidelity Brokerage Services with an aggregate market value of $2,226.29, slated for 09/18/2025. The filing shows those 93 shares were acquired by restricted stock vesting on 09/15/2025 (35 shares) and 09/16/2025 (58 shares) and were received as compensation. The issuer has 59,914,473 shares outstanding, so the proposed sale represents a de minimis fraction of the outstanding stock. The filing also lists multiple insider sales over the past three months, including larger transactions by David Linetsky (e.g., 23,729 shares on 06/27/2025 for $676,195.48). The notice includes the standard signer representations about absence of undisclosed material information.
Phreesia, Inc. (PHR) filed a Form 144 reporting a proposed sale of 93 common shares through Fidelity Brokerage Services with an aggregate market value of $2,226.29, slated for 09/18/2025. The filing shows those 93 shares were acquired by restricted stock vesting on 09/15/2025 (35 shares) and 09/16/2025 (58 shares) and were received as compensation. The issuer has 59,914,473 shares outstanding, so the proposed sale represents a de minimis fraction of the outstanding stock. The filing also lists multiple insider sales over the past three months, including larger transactions by David Linetsky (e.g., 23,729 shares on 06/27/2025 for $676,195.48). The notice includes the standard signer representations about absence of undisclosed material information.
Phreesia, Inc. submitted a Form 144 notice disclosing a proposed sale of 1,064 common shares through Fidelity Brokerage Services on 09/17/2025 with an aggregate market value of $25,004.00. The filing reports 59,914,473 shares outstanding. The 1,064 shares were acquired on 09/11/2025 under a restricted stock vesting arrangement and paid as compensation. The filing also lists multiple sales by Jessica Weiss and David Linetsky during the prior three months, including larger blocks by Mr. Linetsky (e.g., 23,729 shares for $676,195.48 on 06/27/2025). The notice includes the standard attestation that the seller does not possess undisclosed material adverse information.
Phreesia, Inc. submitted a Form 144 notice disclosing a proposed sale of 1,064 common shares through Fidelity Brokerage Services on 09/17/2025 with an aggregate market value of $25,004.00. The filing reports 59,914,473 shares outstanding. The 1,064 shares were acquired on 09/11/2025 under a restricted stock vesting arrangement and paid as compensation. The filing also lists multiple sales by Jessica Weiss and David Linetsky during the prior three months, including larger blocks by Mr. Linetsky (e.g., 23,729 shares for $676,195.48 on 06/27/2025). The notice includes the standard attestation that the seller does not possess undisclosed material adverse information.
Form 144 filed for Phreesia, Inc. (PHR) shows a proposed sale of 2,059 common shares through Fidelity Brokerage Services with an aggregate market value of $48,386.50 and an approximate sale date of 09/17/2025. The shares were acquired by restricted stock vesting on 09/11/2025 and were issued as compensation. The filing reports total outstanding shares of 59,914,473. The filer also disclosed sales by Alison C. Hoffman within the past three months: 1,245 shares on 07/17/2025 for $33,472.82 and 3,133 shares on 09/16/2025 for $72,950.03. The notice includes the standard attestation that the seller is unaware of undisclosed material adverse information.
Form 144 filed for Phreesia, Inc. (PHR) shows a proposed sale of 2,059 common shares through Fidelity Brokerage Services with an aggregate market value of $48,386.50 and an approximate sale date of 09/17/2025. The shares were acquired by restricted stock vesting on 09/11/2025 and were issued as compensation. The filing reports total outstanding shares of 59,914,473. The filer also disclosed sales by Alison C. Hoffman within the past three months: 1,245 shares on 07/17/2025 for $33,472.82 and 3,133 shares on 09/16/2025 for $72,950.03. The notice includes the standard attestation that the seller is unaware of undisclosed material adverse information.
Phreesia, Inc. (PHR) filing reports a proposed sale of 940 common shares through Fidelity Brokerage Services with an aggregate market value of $21,887.34 and approximately 59,914,473 shares outstanding. The securities were acquired on 09/11/2025 through restricted stock vesting and the stated nature of payment is compensation. The filer lists an approximate sale date of 09/16/2025 on the NYSE. The filing also discloses recent open-market sales by the same person totaling 2,391 shares for $65,139.96 across trades dated 07/07/2025–07/18/2025. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Phreesia, Inc. (PHR) filing reports a proposed sale of 940 common shares through Fidelity Brokerage Services with an aggregate market value of $21,887.34 and approximately 59,914,473 shares outstanding. The securities were acquired on 09/11/2025 through restricted stock vesting and the stated nature of payment is compensation. The filer lists an approximate sale date of 09/16/2025 on the NYSE. The filing also discloses recent open-market sales by the same person totaling 2,391 shares for $65,139.96 across trades dated 07/07/2025–07/18/2025. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Phreesia, Inc. (PHR) filed a Form 144 reporting an intended sale of 1,762 common shares with an aggregate market value of $41,027.11, expected to occur on 09/16/2025 on the NYSE. The shares were acquired on 09/11/2025 through restricted stock vesting and were received as compensation.
The filer, identified as Amy Vanduyn, previously sold 640 shares on 07/17/2025 for $17,206.91 and 18,573 shares on 08/25/2025 for $564,055.11. The filing discloses there are 59,914,473 shares outstanding. The document includes the broker name and address (Fidelity Brokerage Services LLC) and a standard attestation that the seller is not aware of undisclosed material adverse information.
Phreesia, Inc. (PHR) filed a Form 144 reporting an intended sale of 1,762 common shares with an aggregate market value of $41,027.11, expected to occur on 09/16/2025 on the NYSE. The shares were acquired on 09/11/2025 through restricted stock vesting and were received as compensation.
The filer, identified as Amy Vanduyn, previously sold 640 shares on 07/17/2025 for $17,206.91 and 18,573 shares on 08/25/2025 for $564,055.11. The filing discloses there are 59,914,473 shares outstanding. The document includes the broker name and address (Fidelity Brokerage Services LLC) and a standard attestation that the seller is not aware of undisclosed material adverse information.
Form 144 filing for Phreesia, Inc. (PHR) shows a proposed sale of 3,133 common shares with an aggregate market value of $72,950.03. The shares were acquired on 09/11/2025 through restricted stock vesting and payment classified as compensation. The planned sale date is 09/16/2025 on the NYSE. The filer reported a prior sale within three months: 1,245 shares sold on 07/17/2025 for $33,472.82. The filing lists total outstanding shares as 59,914,473. Several standard identifying fields (issuer address, filer CIK/CCC, and named filer contact) are not provided in the visible content.
Form 144 filing for Phreesia, Inc. (PHR) shows a proposed sale of 3,133 common shares with an aggregate market value of $72,950.03. The shares were acquired on 09/11/2025 through restricted stock vesting and payment classified as compensation. The planned sale date is 09/16/2025 on the NYSE. The filer reported a prior sale within three months: 1,245 shares sold on 07/17/2025 for $33,472.82. The filing lists total outstanding shares as 59,914,473. Several standard identifying fields (issuer address, filer CIK/CCC, and named filer contact) are not provided in the visible content.
Phreesia, Inc. insider filing notifies a proposed sale of 6,328 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $147,343.68, and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 upon restricted stock vesting as compensation. The filer also reported three sales during the past three months totaling 103,164 shares for gross proceeds of $3,210,162.74 (sales on 07/17/2025, 08/27/2025 and 08/28/2025). The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Phreesia, Inc. insider filing notifies a proposed sale of 6,328 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $147,343.68, and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 upon restricted stock vesting as compensation. The filer also reported three sales during the past three months totaling 103,164 shares for gross proceeds of $3,210,162.74 (sales on 07/17/2025, 08/27/2025 and 08/28/2025). The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 filed for Phreesia, Inc. (PHR) reports a proposed sale of 2,051 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $47,756.30 and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 as restricted stock that vested and were received as compensation. The filer certifies no undisclosed material adverse information. The filing also discloses recent open-market sales by insiders in the past three months, including large disposals by David Linetsky totaling 41,174 shares across June–August 2025 and smaller sales by Jessica Weiss.
Form 144 filed for Phreesia, Inc. (PHR) reports a proposed sale of 2,051 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $47,756.30 and an approximate sale date of 09/16/2025. The shares were acquired on 09/11/2025 as restricted stock that vested and were received as compensation. The filer certifies no undisclosed material adverse information. The filing also discloses recent open-market sales by insiders in the past three months, including large disposals by David Linetsky totaling 41,174 shares across June–August 2025 and smaller sales by Jessica Weiss.